Undefined Category
Browse Posts in Undefined Category
RBCC Aggressively Pursuing Personalized Medicine Opportunities in…
Rainbow Coral Corp. (RBCC) is taking full advantage of more research-friendly regulations.
View ArticleNow Health International and Best Doctors Insurance…
IPMI provider Now Health International today confirms that their investor, the Primary group.
View ArticleResolving IP Disputes in the Pharma Industry
Papula Nevinpat was founded in 1975 and now has an 80-strong team in Finland.
View ArticleDangerous Liaisons: Big Pharma Facing Board-level Scandals…
Why are pharma companies leaving so much to chance?
View ArticleDriving Innovation in Colonoscopy
In March 2014, medical device company, Invendo Medical, closed a US$28m financing round led by new investor Xeraya Capital
View ArticleActavis Announces Trial Results
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI
View ArticleFirst-in-Human Phase 1 Trial of MM-141 Demonstrates…
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting…
View ArticleExplore Other Categories